Completed PHASE2 INTERVENTIONAL 2-arm NCT00149760

Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder

Cognitive Affective Behavior Therapy for Somatization

Sponsor: National Institute of Mental Health (NIMH)

Interventions Augmented Standard Medical Care Cognitive-Affective Behavior Therapy

Updated 5 times since 2017 Last updated: Feb 19, 2014 Started: Aug 31, 2003 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Somatization Disorder and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
Rutgers, The State University of New Jersey

Data source: Rutgers, The State University of New Jersey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Piscataway, United States